Farallon Capital Management »

Dyne Therapeutics shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $212k 6.0k 35.29
2020-09-30 $4.0M 200k 20.19

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
UnitedHealth (UNH)
salesforce (CRM)
Iqvia Holdings (IQV)
Exelixis (EXEL)
Aramark Hldgs (ARMK)
Aon Shs Cl A (AON)
Microsoft Corporation (MSFT)
New York Times Cl A (NYT)
Natera (NTRA)
Ishares Tr Ishares Biotech Put Option (IBB)
Nasdaq Omx (NDAQ)
Transunion (TRU)
Intuit (INTU)

View all positions for Farallon Capital Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
Deep Track Capital
State Street Corporation
Citadel Advisors
TCG Crossover Management
T. Rowe Price Associates
VR Adviser
Goldman Sachs Group
Holocene Advisors

View all funds holding Dyne Therapeutics